Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-07-28 9:23 pm |
N/A N/A |
Icosavax Inc. | ICVX | Yamada Tadataka Director |
0 | $0 | 1,298,340 (Direct) |
View |
2021-05-28 Option Award |
2021-06-01 6:13 pm |
N/A 2031-05-27 |
Athira Pharma Inc. | ATHA | Yamada Tadataka Director |
13,871 | $0 | 13,871 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 6:04 pm |
N/A 2031-05-26 |
Passage BIO Inc. | PASG | Yamada Tadataka Director |
16,918 | $0 | 16,918 (Direct) |
View |
2021-05-21 Option Award |
2021-05-24 5:29 pm |
N/A 2031-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Yamada Tadataka Director |
12,500 | $0 | 12,500 (Direct) |
View |
2021-03-16 Conversion |
2021-03-16 9:51 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Yamada Tadataka and Chairman of the Board |
146,667 | $0 | 13,333 (Direct) |
View |
Ownership |
2021-03-11 9:34 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Yamada Tadataka and Chairman of the Board |
0 | $0 | 403,286 (Direct) |
View |
Ownership |
2020-09-17 8:34 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | Yamada Tadataka Director |
0 | $0 | 109,707 (Direct) |
View |
2020-08-03 Option Award |
2020-08-05 6:33 pm |
N/A N/A |
AGILENT TECHNOLOGIES INC. | A | Yamada Tadataka Director |
212 | $93.91 | 58,374 (Direct) |
View |
2020-05-21 Option Award |
2020-05-22 5:06 pm |
N/A 2030-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Yamada Tadataka Director |
10,000 | $0 | 10,000 (Direct) |
View |